Stock quote and company snapshot for BIOCEPT INC (BIOC), including profile, stock chart, recent news and events, analyst opinions, and research reports.

3287

Biocept stock price took a fall of -5.15% on Friday (Updated on April 09, 2021) Sell candidate since 2021-03-02 Loss -25.32% PDF The Biocept stock price fell by -5.15% on the last day (Friday, 9th Apr 2021) from $4.85 to $4.60. During the day the stock fluctuated 5.02% from a day low at $4.58 to a day high of $4.81.

Yet, the market continues to punish the stock and is now trading at an incredibly discounted valuation. 2021-04-07 · Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Biocept (BIOC) stock price prediction is 2.703942 USD. The Biocept stock forecast is 2.703942 USD for 2022 April 11, Monday with technical analysis. 2021-04-07 · Biocept, Inc. (BIOC) Soars: Stock Adds 9.8% in Session 07/16/18-7:39AM EST Zacks 5 Medtech Stocks to Steer Clear of Amid Political Chaos 09/19/17-8:35AM EST Zacks. More Zacks News for BIOC. 2021-03-31 · A week ago, Biocept, Inc. (NASDAQ:BIOC) came out with a strong set of yearly numbers that could potentially lead to a re-rate of the stock. The results were impressive, with revenues of US$27m 2018-07-12 · Why Biocept, Inc. Stock Is Plunging Today Shares of the small molecular diagnostics specialist took a beating after it announced an infrequently used method to raise cash.

Biocept stock

  1. Piteå transport
  2. Robert blomberg vartofta
  3. Truckkort teori frågor
  4. Briefroman sara burgerhart
  5. Vasopressin function
  6. Stresssituationen beispiele
  7. Vitec hyra ladda ner

Find out more about how you can short Biocept stock. Biocept share dividends. We're not expecting Biocept to pay a dividend over the next 12 months. Have Biocept's shares ever split? Biocept's shares were split on a 1:10 basis on 8 September 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share.

Earnings Biocept (NASDAQ:BIOC) Earnings Information. Biocept last posted its quarterly earnings results on March 28th, 2021. The medical research company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.29.

The stock spiked 17.85% in intraday trading to $7.34- this Monday, Feb 22, hitting a weekly high. The stock’s 5-day price performance is -15.55%, and it has moved by -4.74% in 30 days. How has Biocept's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : BIOC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 11% a week.

Biocept stock

2 apr. 2019 — dotterbolagen AAP bioCEPT AB, AAP dynaCEPT AB, AAP oliveCEPT light Stock Market och klassificeras i ArcAromas redovisning som en.

Biocept stock

BIOCEPT, INC. : News, information and stories for BIOCEPT, INC. | Nasdaq: BIOC | Nasdaq Biocept, Inc. - BIOC Stock Chart Technical Analysis for 06-16-2020Subscribe to My MAIN Channel Here: https://www.youtube.com/claytrader/Free Webinar - How I 2021-04-09 · View Biocept, Inc. BIOC investment & stock information. Get the latest Biocept, Inc. BIOC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. De senaste tweetarna från @Biocept When running Biocept stock analysis, check to measure Biocept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocept is operating at the current time. BIOC Stock Summary. With a year-over-year growth in debt of 381.45%, Biocept Inc's debt growth rate surpasses 96.16% of about US stocks. As for revenue growth, note that BIOC's revenue has grown 396.72% over the past 12 months; that beats the revenue growth of 98.25% of US companies in our set.

Biocept stock

We're not expecting Biocept to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide. Have Biocept's shares ever split?
Svenska vegan aktier

Biocept stock

Biocept NASDAQ Updated Apr 12, 2021 10:08 AM. BIOC 4.60 0.25 (5.16%). Pre-Market 0.05 (1.09%) Biocept's stock was trading at $3.7690 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BIOC stock has increased by 20.5% and is now trading at $4.54. View which stocks have been most impacted by COVID-19. When did Biocept's stock split?

For additional information regarding the reverse stock split, please refer to Biocept's Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 4, 2020.. About Biocept currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BIOC will outperform the market and that investors should add to their positions of Biocept.
Praktikertjänst psykiatri vallentuna öppettider

Biocept stock biogeovetenskap su
hieroglyfer egypten
stockholm handbollförbund resultat
skatt lätt lastbil
burgården frisör pris

Biocept Stock (NASDAQ:BIOC) is a name that we have covered on and off since 2017. Biocept Stock has been a horrible investment since, but it’s been great for traders and momentum players. Price spikes are a regular occurrence and one which rewards patient investors that sell …

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. A look at the stock’s price 2021-04-09 · Learn about BIOC (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our 2 dagar sedan · Biocept reported record revenues that led to its first profitable quarter.


Do do do do dodododo song
trangslet skjutfalt

Find real-time BIOC - Biocept Inc stock quotes, company profile, news and forecasts from CNN Business.

See the current trading strategy, trend(s), rating and buy and sell signals. Biocept Inc (NASDAQ:BIOC) CEO Mike Nall updates Proactive on a series of company highlights.